Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH  

Reproduction Advance Publication first posted online on 19 August 2008

(Reproduction 2008;136:657.)

Reproduction (2008)
DOI: 10.1530/REP-08-0159
Copyright © 2008 Society for Reproduction and Fertility
This Article
Right arrow Accepted Manuscript (PDF)
Right arrow All Versions of this Article:
136/5/657    most recent
REP-08-0159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Nation, A.
Right arrow Articles by Selwood, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nation, A.
Right arrow Articles by Selwood, L.

RESEARCH

VAP1; A novel ovarian immunocontraceptive target in the common brushtail possum, Trichosurus vulpecula

Angela Nation, Shuliang Cui and Lynne Selwood

A Nation, Zoology, The University of Melbourne, Melbourne, Australia
S Cui, Zoology, The University of Melbourne, Melbourne, Australia
L Selwood, Zoology, University of Melbourne, Melbourne, Australia

Correspondence: Angela Nation, Email: a.nation{at}pgrad.unimelb.edu.au

Abstract

Ovarian-based immunological research is currently restricted to proteins of the zona pellucida. This study examined the immunocontraceptive potential of a novel vesicle-associated oocyte protein, VAP1, previously isolated from the vesicle-rich hemisphere of the brushtail possum oocyte. Seven female possums were immunized against recombinant GST-VAP1 fusion protein. Control animals (n=3) received antigen-free vaccinations. Following immunization, regular blood sampling determined the level and duration of immune response. Animals were monitored daily, pre- and post-immunization, to determine oestrous cycling activity and the percentage of reproductive cycles yielding viable young. The reproductive tracts and somatic organs of VAP1 immunized (n=7), control immunized (n=3) and non-immunized (n=5) animals were collected and examined by histology and transmission electron microscopy. VAP1 immunization caused a strong and sustained immune response. Elevated levels of VAP1 antibody binding were detected in sera following initial injections, and immune titres rose as boosters were administered. Immunization had no adverse effect upon animal behaviour or body condition. Immunized females demonstrated no major change in annual oestrous cycling activity, however the percentage of reproductive cycles resulting in pouch young decreased significantly (p<0.05) by 40 %. Histological and ultrastructural analysis revealed an abundance of lipid-like degradation bodies within the ooplasm of developing oocytes and the cytoplasm of failing uterine zygotes. Active macrophage invasion of enlarged endometrial glands was observed in the uteri of two females. Reproductive tract changes are discussed in relation to observed fertility decline. The results of this study indicate that VAP1 has exciting potential as an immunocontraceptive target for possum control in New Zealand.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH  
Copyright © 2008 by the Society for Reproduction and Fertility.